Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Adverse Events During Intensive Induction Chemotherapy For Acute Myeloid Leukemia (AML) Or High-Grade Myelodysplastic Syndromes (MDS)

Sarah A. Buckley, MD, Megan Othus, PhD, Vladimir Vainstein, MD MSc, Janis L. Abkowitz, MD, Elihu H. Estey, MD, Roland B. Walter, MD, PhD

Blood (2013) 122 (21): 3899.

https://doi.org/10.1182/blood.V122.21.3899.3899

Published: 2013

Journal Articles

Rapid Rate of Peripheral Blood Blast Clearance Accurately Predicts Complete Remission in Acute Myeloid Leukemia

Vladimir Vainstein, MD MSc, Sarah A. Buckley, MD, Shukron Ofir, MSc, Elihu H. Estey, MD, Janis L Abkowitz, MD, Brent L. Wood, MD, PhD, Roland B. Walter, MD, PhD

Blood (2012) 120 (21): 3551.

https://doi.org/10.1182/blood.V120.21.3551.3551

Published: 2012

Journal Articles

Combining Dose-Response Slope with in Vitro Sensitivity to ABL Tyrosine Kinase Inhibitors As an Improved Correlative Metric for Predicting Clinical Response in Chronic Myeloid Leukemia

Vladimir Vainstein, MD MSc, Christopher A. Eide, Thomas O'Hare, PhD, Brian J. Druker

Blood (2012) 120 (21): 1670.

https://doi.org/10.1182/blood.V120.21.1670.1670

Published: 2012

Journal Articles

Predicting Duration of Neutropenia After Successful Intensive Induction Chemotherapy for Acute Myeloid Leukemia or High-Grade Myelodysplastic Syndromes

Sarah A. Buckley, MD, Vladimir Vainstein, MD MSc, Janis L. Abkowitz, MD, Elihu H. Estey, MD, Roland B. Walter, MD, PhD

Blood (2012) 120 (21): 4336.

https://doi.org/10.1182/blood.V120.21.4336.4336

Published: 2012

Journal Articles

Clinical Validation of a Physiologically-Based Computer Model of Human Granulopoiesis and Its Use for Improving Cancer Therapy by Doxorubicin and Granulocyte Colony-Stimulating Factor (GCSF).

Vladimir Vainstein, MD, MSc, Yuval Ginosar, PhD, Meir Shoham, MSc, Anton Ianovski, MSc, Alexander Rabinovich, Yuri Kogan, Vera Selitser, Samuel Ariad, MD, Stephen Chan, MD, Zvia Agur, PhD

Blood (2006) 108 (11): 3848.

https://doi.org/10.1182/blood.V108.11.3848.3848

Published: 2006

NARROW

Adverse Events During Intensive Induction Chemotherapy For Acute Myeloid Leukemia (AML) Or High-Grade Myelodysplastic Syndromes (MDS)

Rapid Rate of Peripheral Blood Blast Clearance Accurately Predicts Complete Remission in Acute Myeloid Leukemia

Combining Dose-Response Slope with in Vitro Sensitivity to ABL Tyrosine Kinase Inhibitors As an Improved Correlative Metric for Predicting Clinical Response in Chronic Myeloid Leukemia

Predicting Duration of Neutropenia After Successful Intensive Induction Chemotherapy for Acute Myeloid Leukemia or High-Grade Myelodysplastic Syndromes

Clinical Validation of a Physiologically-Based Computer Model of Human Granulopoiesis and Its Use for Improving Cancer Therapy by Doxorubicin and Granulocyte Colony-Stimulating Factor (GCSF).

Email alerts

ASH Publications

American Society of Hematology

Adverse Events During Intensive Induction Chemotherapy For Acute Myeloid Leukemia (AML) Or High-Grade Myelodysplastic Syndromes (MDS)

Rapid Rate of Peripheral Blood Blast Clearance Accurately Predicts Complete Remission in Acute Myeloid Leukemia

Combining Dose-Response Slope with in Vitro Sensitivity to ABL Tyrosine Kinase Inhibitors As an Improved Correlative Metric for Predicting Clinical Response in Chronic Myeloid Leukemia

Predicting Duration of Neutropenia After Successful Intensive Induction Chemotherapy for Acute Myeloid Leukemia or High-Grade Myelodysplastic Syndromes

Clinical Validation of a Physiologically-Based Computer Model of Human Granulopoiesis and Its Use for Improving Cancer Therapy by Doxorubicin and Granulocyte Colony-Stimulating Factor (GCSF).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only